Brief: Qualigen Therapeutics Divests Fastpack Diagnostics Business

Aixcrypto Holdings

24/07/2023 14:14

July 24 (Reuters) - Qualigen Therapeutics Inc  QLGN.O :
    * QUALIGEN THERAPEUTICS DIVESTS FASTPACK® DIAGNOSTICS
BUSINESS
    * QUALIGEN THERAPEUTICS INC- ALL CASH DEAL WITH CHEMBIO
DIAGNOSTICS, A US SUBSIDIARY OF FRENCH DIAGNOSTICS COMPANY
BIOSYNEX, SA,
    * QUALIGEN THERAPEUTICS INC - ALL CASH TRANSACTION, WHICH
CLOSED
ON JULY 20, 2023, ENABLES COMPANY TO FURTHER STREAMLINE
OPERATIONS
    * QUALIGEN THERAPEUTICS- DEAL ENABLES COMPANY TO FOCUS
PARTICULARLY ON QN-302 AND ITS PRE-CLINICAL PAN-RAS INHIBITOR
PLATFORM

Source text for Eikon:  ID:nGNXcg0mVz 
Further company coverage:  QLGN.O 

 ((Reuters.Briefs@thomsonreuters.com;))